期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Detection of Microvesicle miRNA Expression in ALL Subtypes and Analysis of Their Functional Roles 被引量:3
1
作者 李雯英 陈小梅 +3 位作者 熊薇 郭冬梅 卢力 李慧玉 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2014年第5期640-645,共6页
Microvesicles (MVs) are the heterogeneous mixtures of vesicles. MVs released by leukemia cells constitute an important part of the leukemia microenvironment. MVs might act as important reser- voirs of microRNAs (mi... Microvesicles (MVs) are the heterogeneous mixtures of vesicles. MVs released by leukemia cells constitute an important part of the leukemia microenvironment. MVs might act as important reser- voirs of microRNAs (miRNAs). It is worth evaluating whether MVs possess some unique miRNA con- tents that are valuable in understanding the pathogenesis. In this study, we investigated the miRNA ex- pression patterns of Nalm-6-derived MVs, Jurkat-derived MVs and normal cell-derived MVs using miRNA microarrays. The potential target genes regulated by differentially expressed miRNAs were also predicted and analyzed. Results demonstrated that 182 miRNAs and 166 miRNAs were differentially expressed in Nalm-6-MVs and Jurkat-MVs, respectively. Many oncogenes, tumor suppressors and sig- nal pathway genes were targeted by these aberrantly expressed miRNAs, which might contribute to the development of B-ALL or T-ALL. Our findings expanded the potential diagnostic markers of ALL and provided useful information for ALL pathogenesis. 展开更多
关键词 MICROVESICLES miRNA expression profiles acute lymphoblastic leukemia subtypes
暂未订购
A multicenter prospective study of next-generation sequencing-based newborn screening for monogenic genetic diseases in China 被引量:11
2
作者 Ru-Lai Yang Gu-Ling Qian +14 位作者 Ding-Wen Wu Jing-Kun Miao Xue Yang Ben-Qing Wu Ya-Qiong Yan Hai-Bo Li Xin-Mei Mao Jun He Huan Shen Hui Zou Shu-Yuan Xue Xiao-Ze Li Ting-Ting Niu Rui Xiao Zheng-Yan Zhao 《World Journal of Pediatrics》 SCIE CSCD 2023年第7期663-673,共11页
Background Newborn screening(NBS)is an important and successful public health program that helps improve the long-term clinical outcomes of newborns by providing early diagnosis and treatment of certain inborn disease... Background Newborn screening(NBS)is an important and successful public health program that helps improve the long-term clinical outcomes of newborns by providing early diagnosis and treatment of certain inborn diseases.The develop-ment of next-generation sequencing(NGS)technology provides new opportunities to expand current newborn screening methodologies.Methods We designed a a newborn genetic screening(NBGS)panel targeting 135 genes associated with 75 inborn disorders by multiplex PCR combined with NGS.With this panel,a large-scale,multicenter,prospective multidisease analysis was conducted on dried blood spot(DBS)profiles from 21,442 neonates nationwide.Results We presented the positive detection rate and carrier frequency of diseases and related variants in different regions;and 168(0.78%)positive cases were detected.Glucose-6-Phosphate Dehydrogenase deficiency(G6PDD)and phenylketonuria(PKU)had higher prevalence rates,which were significantly different in different regions.The positive detection of G6PD variants was quite common in south China,whereas PAH variants were most commonly identified in north China.In addi-tion,NBGS identified 3 cases with DUOX2 variants and one with SLC25A13 variants,which were normal in conventional NBS,but were confirmed later as abnormal in repeated biochemical testing after recall.Eighty percent of high-frequency gene carriers and 60%of high-frequency variant carriers had obvious regional differences.On the premise that there was no significant difference in birth weight and gestational age,the biochemical indicators of SLC22A5 c.1400C>G and ACADSB c.1165A>G carriers were significantly different from those of non-carriers.Conclusions We demonstrated that NBGS is an effective strategy to identify neonates affected with treatable diseases as a supplement to current NBS methods.Our data also showed that the prevalence of diseases has significant regional charac-teristics,which provides a theoretical basis for screening diseases in different regions. 展开更多
关键词 Monogenic genetic diseases Newborn screening Next-generation sequencing Monogenic genetic diseases Regional features
原文传递
Digital gene expression profiling analysis of A549 cells cultured with PM10 in moxa smoke 被引量:1
3
作者 Xin Hui Ping Liu +7 位作者 Li Han Chang Huang Zhihua Yang Maoxiang Zhu Bicheng Yang Ruoxi Li Zhixiu Lin Baixiao Zhao 《Journal of Traditional Chinese Medical Sciences》 2020年第4期404-412,共9页
Background:Moxibustion is a traditional Chinese medicine therapy to cure diseases by fumigating meridians or affected parts via burning of moxa floss.Moxa smoke(MS)is one of the key factors in moxibustion.In this stud... Background:Moxibustion is a traditional Chinese medicine therapy to cure diseases by fumigating meridians or affected parts via burning of moxa floss.Moxa smoke(MS)is one of the key factors in moxibustion.In this study,we adopted digital gene expression profiling,a next-generation gene sequencing technology,to investigate the effect of MS,inhalable particulate matter(PM10),on human lung adenocarcinoma A549 cells.Methods:The effects of MS PM10 on A549 cells,over different treatment durations were investigated in different groups:the 4-h group(4-h MS group and 4-h control group)and the 20-h group(20-h MS group and 20-h control group).Samples collected from the four groups were stored at80C for subsequent digital gene expression analysis.The differentially expressed genes(DEGs),identified after PM10 treatment,were screened,and their expression patterns analyzed by cluster analysis,Gene Ontology term enrichment,and Kyoto Encyclopedia of Genes and Genomes pathway analysis.Results:Compared with two control groups,1109 DEGs were identified after 4 h of MS intervention and 3565 DEGs were found after 20 h of MS intervention,respectively.Compared with that after 4-h intervention,2149 DEGs were identified after 20-h intervention.Cluster analysis demonstrated that PM10 can significantly inhibit cell cycle process with the prolongation of intervention time.Significant pathway enrichment analysis showed that MS PM10 can inhibit A549 cell cycle process at all phases.When MS PM10 exposure time prolongs,the inhibitory effect on cell cycle process becomes more obvious.Conclusion:MS PM10 has many biological activities,and may cause differential expression of genes involved in various biological processes.Nevertheless,further research on MS is warranted for better understanding of the mechanistic details. 展开更多
关键词 Moxa smoke Particulate matter Digital gene expression MOXIBUSTION A549 cells
暂未订购
Optimization and application of a dried blood spot-based genetic screening method for thalassemia in Shenzhen newborns 被引量:4
4
作者 Wei Wen Meng Guo +1 位作者 Hong-bing Peng Li Ma 《World Journal of Pediatrics》 SCIE CAS CSCD 2019年第6期610-614,共5页
Background To optimize and apply an approach suitable for large-scale neonatal thalassemia genetic screening in China,thalassemia genotypes were determined by polymerase chain reaction-reverse dot blot using DNA extra... Background To optimize and apply an approach suitable for large-scale neonatal thalassemia genetic screening in China,thalassemia genotypes were determined by polymerase chain reaction-reverse dot blot using DNA extracted from dried blood spots(DBS)obtained from newborn screening programs.Methods Firstly,the most suitable commercial DNA extraction kit for DBS was screened.Then,the appropriate amount of DBS required for the automated high-throughput DNA extraction system was evaluated.Finally,the thalassemia prevalence and genotype spectrum in Shenzhen were investigated in 2028 newborns using the optimized screening procedure.Results The Magentec extraction kit was best suited for the automated DBS DNA extraction system using eight 3-mm DBS discs.The neonatal thalassemia prevalence in Shenzhen was 9.12%;6.31%α-thalassemia,2.37%β-thalassemia,and 0.44%α-/β-thalassemia.Conclusions Genetic screening based on DBS can precisely identify the thalassemia genotypes.Bothα-andβ-thalassemia are widely distributed in Shenzhen newborns.Newborn genetic screening is important for establishing a comprehensive thalassemia prevention program and for public education. 展开更多
关键词 DRIED blood spot Genetic SCREENING NEWBORN SCREENING THALASSEMIA
原文传递
Pre-symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post-birth:14-month safety and developmental outcomes
5
作者 Zhihao Sun Liping Wu +5 位作者 Yufan Hui Yuhang Zhong Jiangtao Yang Zhiyong Sun Xiaoling Huang Hui Xiong 《Pediatric Investigation》 2025年第2期201-202,共2页
To the editor:Spinal muscular atrophy(SMA)is a severe autosomal recessive neuromuscular disorder with an incidence of approximately one in 10000 live births.Patients exhibit progressive muscle weakness and atrophy,wit... To the editor:Spinal muscular atrophy(SMA)is a severe autosomal recessive neuromuscular disorder with an incidence of approximately one in 10000 live births.Patients exhibit progressive muscle weakness and atrophy,with the most severe type 1 cases often leading to mortality before the age of 2 years.The advent of disease-modifying therapies(DMTs)has altered the natural history of SMA,and multiple real-world cohort studies have revealed the benefit of early access to disease-modifying therapies,1,2 thus necessitating new management strategies for evolving patient needs.Two DMTs,nusinersen(SPINRAZA)and risdiplam(EVRYSDI)have been approved for use in China.Specifically,the oral dispersible formulation of risdiplam is indicated for the treatment of SMA patients aged 16 days and older in China,while it has been approved by the Food and Drug Administration for use in patients of all ages in the United States since 2022.On the other hand,local pilot studies on SMA newborn screening(NBS)are also being conducted in China. 展开更多
关键词 Pre symptomaticTreatment SpinalMuscularAtrophy Risdiplam muscular atrophy sma NewbornScreening DevelopmentalOutcomes SafetyOutcomes
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部